Studies have been initiated to make the Covid-19 vaccine BioNTech in Family Health Centers (ASM), which meet the criteria for providing appropriate storage conditions by the Ministry of Health. Carrying out the social immunization process with Sinovac and BioNTech vaccines, which are approved for “emergency use” in the fight against Covid-19, the Ministry of Health took action to vaccinate the society in a shorter time in parallel with the vaccine supply. The roadmap followed in…"Work has been initiated to make BioNTech vaccine in ASMs with suitable storage conditions."
Many people initially kept a distance from the BioNTech vaccine, claiming that the mRNA technology used in the BioNTech vaccine is new, and it is not yet known what problems a vaccine developed in such a short time will cause in the long run. Prof. Dr. Osman Müftüoğlu shared what should be known about mRNA vaccines in his article today. Many people initially kept a distance from the BioNTech vaccine, claiming that the mRNA technology…"Will the BioNTech vaccine cause problems in the future?"
Türkiye’nin ilave 90 milyon doz alım için anlaştığı Biontech aşısı nedir, ne değildir? Prof. Dr. Osman Müftüoğlu, mRNA teknolojisiyle geliştirilen aşıyla ilgili 17 soruya köşesinden yanıt verdi. ntv.com.tr 24.05.2021 – 10:44 | Son Güncelleme : 24.05.2021 – 10:50 Türkiye, Amerikan ilaç şirketi Pfizer ile Alman biyoteknoloji firması BioNTech’in geliştirdiği Covid aşısıyla ilgili yeni bir anlaşma yaptı. …"Biontech aşısı hakkında her şey – Sağlık Haberleri"
Europe’s drug regulatory agency reported that the storage period of the corona virus vaccine developed by BioNTech – Pfizer can be increased from five days to 31 days at normal refrigerator temperatures. The European Medicines Agency (EMA) stated that the vaccine can be easily distributed to non-refrigerated areas after this situation, and underlined that the change to be made applies to unopened vaccine bottles. The EMA observer informed Reuters that the announcement was made after…"BioNTech vaccine statement from the European Medicines Agency"
German biotech firm BioNTechreportedly plans to establish a regional center and a new production facility for vaccines based on mRNA (messenger RNA) technology in Singapore. In the statement made by BioNTech, it was stated that the Singapore office, which will be the regional center for Southeast Asia, is planned to open in 2021. 80 PEOPLE EMPLOYMENT WILL BE PROVIDED In the statement that the company is working to expand its production network, it was stated…"BioNTech to build mRNA production facility in Singapore – Health News"
385 thousand people with BioNTech vaccine were examined in Qatar. It was determined that the German vaccine was effective against variants in England, South Africa and India. Stating that the results in Qatar are very important, Radiology expert Dr. Güner Sönmez pointed out that there is a noticeable decrease in the number of cases in Turkey with the effect of the closure and vaccination reaching 8 percent of the population. (News: Sea Hairless)"385 thousand people examined: BioNTech vaccine is effective in all variants"
Hope to the world with the vaccine developed with the US pharmaceutical giant Pfizer within the scope of combating the Corona virus epidemic. BioNTechCo-founder and CEO Prof. Dr. Uğur Şahin made a statement at the panel organized online by the British Financial Times newspaper. Hawk, corona virusAnnouncing that they are working on a different version of the vaccine developed against the vaccine that can be stored in refrigerators at 2 to 8 degrees Celsius for…"BioNTech CEO Şahin: a new version of the vaccine is being developed"
Process in the coronavirus epidemic; As we all know, it is advancing in favor of our citizens in our country. During the pandemic; Incidence rate and mortality rates are accepted criteria all over the world. As a result of the measures taken; a decrease in case and death rates is expected. The important thing now is that these values either approach zero, or zero. For this, it is very necessary to make some sacrifices and…"Biontech vaccine or Sinovac vaccine? Which vaccine should we choose? Which vaccine is more effective? Here is the Sinovac and Biontech vaccine in 6 items!"
It was reported that the new type of corona virus vaccine developed by German vaccine manufacturer BioNTech and its US partner Pfizer applied to the European Medicines Agency (EMA) for use in children between the ages of 12 and 15. In the statement made by the BioNTech company, it was stated that the EMA application was made for children between the ages of 12-15 and the vaccine could be applied in this age group in…"BioNTech applied to EMA for the use of Covid-19 vaccine in the 12-15 age range – Health News"
Scientist BioNTech CEO Uğur Şahin, who developed the first approved vaccine within the scope of combating Covid-19, said that they wanted to give Turkey as many vaccines as possible, but these vaccines should be produced first. Speaking in front of the press members, Şahin reminded that they had been meeting with Minister of Health Fahrettin Koca for weeks and said, “Now we have delivered the first doses. We are talking about sending much more to…"Uğur Şahin announced when Biontech vaccine will be sent to Turkey – health news"